ALK+ International is proud to introduce it's new weekly lottery! 🎰

We receive 40% of ticket price regardless of winner status so why not give it a try today and be in to win up to £25,000! 💸👛💸

www.givinglottery.org.uk/support/alk-...

#Action4Alk

#TogetherWeCan

ALK+ International needs you to invest in hope today and donate to vital medical research into ALK+ cancer.

Whatever you do, big or small makes a difference join us and take #ACTION4ALK

#TogetherWeCan Further ALK+ Research

#MoreResearchMoreLife
#ALKCancer
#ALKPositive
#LungCancer
#Stage4

ALK+ International is looking for Volunteers!

If you believe that research saves lives come and join our team and help us further ALK+ cancer research.

#Action4Alk
#TogetherWeCan Further ALK+ Research

In 2022, ALK+ International surveyed 130 ALK+ cancer patients from Europe. Today's post looks at the results of waiting times around biomarker testing.
How long did you have to wait?

Check out our LCAM campaign here:
www.alkinternational.org/lcam

#Action4Alk
#ALKCancer
#ALKPositive
#LungCancer

Lung Cancer Awareness Month ALK+ Story updates.

Hayley was diagnosed in November 2021. Read her update on our website here:
www.alkinternational.org/alk-stories

Check out our LCAM campaign here:
www.alkinternational.org/lcam

#Action4Alk
#LungCancerAwarenessMonth
#LungCancer
#LCAM

In 2022, ALK+ International surveyed 130 ALK+ patients from Europe. 69.5% of people said they would enter into a clinical trial upon progression, even if they still had further lines of treatment available to them.

Check out our LCAM campaign:
www.alkinternational.org/lcam

#Action4Alk
#LCAM